What is medCPU?
medCPU is a technology company specializing in the review and benchmarking of consumer electronics, particularly laptops, tablets, and 2-in-1 devices. The company provides in-depth, hands-on insights and practical tips designed to help users make informed purchasing decisions. Its target audience spans professionals, students, and gamers, offering tailored recommendations and comparisons of various computing hardware. With a foundation built on over fifteen years of tech blogging experience and a decade in healthcare technology solutions, medCPU aims to leverage its technological expertise across diverse industry sectors. The platform is a valuable resource for understanding the latest trends and performance metrics in the personal computing market.
How much funding has medCPU raised?
medCPU has raised a total of $48.6M across 4 funding rounds:
Series A
$1.3M
Series B
$9.3M
Debt
$3M
Other Financing Round
$35M
Series A (2011): $1.3M, investors not publicly disclosed
Series B (2014): $9.3M led by New Richmond Ventures and Easton Capital Partners
Debt (2015): $3M supported by Silicon Valley Bank
Other Financing Round (2016): $35M featuring UPMC and Merck Global Health Innovation Fund
Key Investors in medCPU
New Richmond Ventures
New Richmond Ventures is a venture capital firm founded by Richmond natives Jim Ukrop, Bob Mooney, and Ted Chandler, focused on igniting and advancing creativity and innovation within the region by providing experienced counsel, valuable connections, and accessible capital to scaling startups and local ventures.
Easton Capital Partners
Easton Capital Investment Group manages approximately $200 million across three funds, making investments ranging from $2 million to $7.5 million and leveraging strategic co-investment relationships for larger funding rounds.
UPMC
UPMC (University of Pittsburgh Medical Center) is a leading integrated health services provider and insurer, known for its innovation in healthcare delivery and technology.
What's next for medCPU?
The recent major strategic investment in medCPU signals a pivotal phase for the company, likely focused on scaling its operations, enhancing its platform capabilities, and expanding its market reach. This infusion of capital, coupled with the company's established expertise in tech analysis and its history of securing diverse forms of financing, positions medCPU for accelerated growth. Future endeavors may include strategic partnerships, further development of its benchmarking tools, and potentially exploring new verticals where its technology insights can be applied. The company's ability to attract significant backing suggests strong investor confidence in its business model and future potential.
See full medCPU company page
